Evidence map›Paper›PMID 23877030›Full record

ArticleHuman vaccines & immunotherapeutics2013

DNA electroporation in rabbits as a method for generation of high-titer neutralizing antisera: examples of the botulinum toxins types A, B, and E.

Aurore Burgain, Alice Rochard, Capucine Trollet, Christelle Mazuet, Michel R Popoff, Virginie Escriou, Daniel Scherman, Pascal Bigey

Open access · bronzeAbstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Aurore BurgainUniversité Paris Descartes; Paris, France; ENSCP Chimie ParisTech; Paris, France; CNRS UMR8151; Paris, France; Inserm U1022; Paris, France.
Alice RochardUniversité Paris Descartes; Paris, France; ENSCP Chimie ParisTech; Paris, France; CNRS UMR8151; Paris, France; Inserm U1022; Paris, France.
Capucine TrolletUniversité Paris Descartes; Paris, France; ENSCP Chimie ParisTech; Paris, France; CNRS UMR8151; Paris, France; Inserm U1022; Paris, France.
Christelle MazuetUnité des Bactéries Anaérobies et Toxines; Paris, France.
Michel R PopoffUnité des Bactéries Anaérobies et Toxines; Paris, France.
Virginie EscriouUniversité Paris Descartes; Paris, France; ENSCP Chimie ParisTech; Paris, France; CNRS UMR8151; Paris, France; Inserm U1022; Paris, France.
Daniel SchermanUniversité Paris Descartes; Paris, France; ENSCP Chimie ParisTech; Paris, France; CNRS UMR8151; Paris, France; Inserm U1022; Paris, France.
Pascal BigeyUniversité Paris Descartes; Paris, France; ENSCP Chimie ParisTech; Paris, France; CNRS UMR8151; Paris, France; Inserm U1022; Paris, France.
Centre National de la Recherche Scientifique · FRChimie ParisTech · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Raising high titer antibodies in animals is usually performed by protein immunization, which requires the long and sometimes difficult step of production of the recombinant protein. DNA immunization is an alternative to recombinant proteins, only requiring the building of an eukaryotic expression plasmid. Thanks to efficient DNA delivery techniques such as in vivo electroporation, DNA vaccination has proven useful the last few years. In this work, we have shown that it is possible to raise very high antibody titers in rabbit by DNA electroporation of an antigen encoding plasmid in the skeletal muscle with the right set of electrodes and rabbit strain. In a model of botulinum toxins types A and E, the neutralizing titers obtained after three treatments were high enough to fit the European Pharmacopeia, while it did not for type B toxin. Furthermore, the raised antibodies have high avidity and are suitable for in vitro and in vivo immunodetection of proteins.

Indexed as

AnimalsAntibodies, BacterialAntibodies, NeutralizingAntibody AffinityAntitoxinsBotulinum ToxinsBotulinum Toxins, Type AElectroporationFemaleImmune SeraMaleMiceRabbitsVaccines, DNAAntibodies, BacterialAntibodies, NeutralizingAntitoxinsBotulinum ToxinsBotulinum Toxins, Type Abotulinum toxin type EImmune SerarimabotulinumtoxinBVaccines, DNAantiserumbotulinum neurotoxinDNA immunizationelectroporationneutralizing antibodies

Identifiers

PMID23877030
PMCPMC3906399
OpenAlexW1972252665

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.